Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Neurones S.A. Earnings Release 2014

Sep 10, 2014

1548_iss_2014-09-10_3293b85d-6204-42dc-9db2-1c04166b00b2.pdf

Earnings Release

Open in viewer

Opens in your device viewer

PRESS INFORMATION

Heading: 1st half 2014 results Nanterre, September 10, 2014

1 st half 2014 operating profit stands at 9.1%

Accounts at June 30 (audited in € millions) H1 2014 H1 2013 2013
Revenues 177.1 168.5 343.2
Business operating profit (*) 16.5 (9.3%) 15.4 (9.2%) 34.1 (9.9%)
Operating profit 16.1 (9.1%) 14.8 (8.8%) 32.9 (9.6%)
Net financial income 1.1 1.0 1.9
Corporate income tax (6.4) (6.1) (13.4)
Net profit after tax 10.8 (6.1%) 9.7 (5.8%) 21.4 (6.2%)
of which, group share 9.4 8.3 18.6
Staff at end of period 4,016 3,847 4,065

(*) Prior to cost of bonus shares, stock options and impairment of assets.

Achievements

As previously announced, the 5.1% growth in revenues was entirely organic. The number of employees remained virtually stable over the period.

Operating profit was up 9%, representing an operating margin of 9.1% of revenues. Net profit increased by 11%.

The Group's net cash also grew to €100.8 million, compared with €84.7 million on June 30, 2013.

Outlook

Overall, for 2014, NEURONES maintains its forecast to achieve annual revenues in the region of €360 million and an operating profit of around 9% of revenues.

About NEURONES

With 4,000 people, the NEURONES group is specialized in Consulting (Management and Organization) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems.

NYSE Euronext: Compartment B – ISIN code: FR0004050250 – NYSE symbol: NRO www.neurones.net

Press Relations: Florence Gillier Communication Frédérique Guillo Tel.: +33 (0)1 41 18 85 55 [email protected]

NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 [email protected]

Investor relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 [email protected]